Park Square is pleased to announce the placement of Maureen Suda as Vice President and Head of Communications at Deep Genomics. Deep Genomics is a pioneering biotechnology company that leverages artificial intelligence and genome biology to discover and develop life-saving genetic therapies.

Suda most recently spent four years as Vice President, Corporate Communications at Sage Therapeutics. Previously, she founded and led a communications and public relations firm, Suda Communications, in which she advised biotech and health science companies on a broad range of strategic communications issues. Earlier in her career, she held roles of increasing responsibility in communications and public policy at Millennium Pharmaceuticals.

Suda received her B.A. in Economics and History from the University at Buffalo and her M.S. in Public Relations from Boston University.  

Park Square Executive Search serves companies and institutions that are shaping the world through discovery, innovation and growth. Our clients are leading life sciences and healthcare organizations, technology companies, major research universities, and venture capital and private equity firms, including their portfolio companies. We place board members, chief executive officers, C-suite executives, and academic leaders.